Form 8-K - Current report:
SEC Accession No. 0001104659-22-083530
Filing Date
2022-07-28
Accepted
2022-07-28 11:26:15
Documents
14
Period of Report
2022-07-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222062d1_8k.htm   iXBRL 8-K 23922
2 EXHIBIT 99.1 tm2222062d1_ex99-1.htm EX-99.1 7633
3 GRAPHIC logo.jpg GRAPHIC 2506
  Complete submission text file 0001104659-22-083530.txt   213061

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20220728.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20220728_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20220728_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2222062d1_8k_htm.xml XML 3730
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 221113591
SIC: 2834 Pharmaceutical Preparations